FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 334:1270-1271 May 9, 1996 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Henderson, I. C. PubMed Citation

To the Editor: We were intrigued by the editorial by Dr. Henderson entitled "Paradigmatic Shifts in the Management of Breast Cancer" (April 6, 1995, issue).¹ Of particular interest are the questions he asks about the effect of adjuvant therapy: "Are some patients cured by adjuvant treatment whereas others derive no benefit at all? Or is the survival of most patients prolonged only transiently, with no patients or very few cured?"

Patients with breast cancer are eager to be shown the true balance sheet regarding adjuvant therapy. In return for a few months of toxic effects, is there an increase in . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.